ArticleTranslational lung cancer research2024

Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with leptomeningeal metastases harboring targetable mutations.

Xiaoyu Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.